India city Hyderabad vaccine India city Hyderabad

Bharat Biotech completes trials for India's first intranasal Covid vaccine

Reading now: 578
www.livemint.com

Bharat Biotech on Monday announced that it has completed clinical development for phase III trials and booster doses for BBV154 intranasal covid vaccine.

Speaking about the same, the Hyderabad-based company said, “BBV154 has proven to be safe, well-tolerated & immunogenic in subjects in controlled clinical trials.".

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA